Back

AchieveCE

  • Measles
  • Vaccination
  • Vitamin A

Measles Recognition, Prevention, and Outbreak Response

Measles is again a working diagnosis in United States healthcare rather than a historical one. Confirmed cases have climbed each year since 2023; the large majority are outbreak-associated, and the interval between a patient’s arrival and the first suspicion of measles is where transmission can occur. This course prepares interprofessional healthcare teams to shorten that interval. It reviews the epidemiology behind the resurgence; prodromal, cutaneous, and oral findings that support recognition; and the milder presentations seen in partially immune patients. It then addresses role-appropriate responses across medical, nursing, pharmacy, and dental settings, including source control, airborne precautions, diagnostic-testing workflows, immediate public-health notification, exposure investigation, immunity assessment, MMR vaccination, postexposure prophylaxis, medication safety, and occupational-health management. The course closes with supportive management, complication monitoring, vitamin A and other treatment questions, patient education, and communication with vaccine-hesitant families. Case studies and knowledge checks distinguish independent clinical decisions from nursing, pharmacy, dental, technical, and supportive responsibilities so that learners can translate measles guidance into actions appropriate to their professional role.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 2 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Paid

This provider typically $19–30

See fees on achievece.com

Listed by the provider

  • Enduring / On-demand
  • Credit · Up to 2 credits
  • Paid · this provider typically $19–30
  • Released
    Aug 12, 2026
  • Last day to claim credit
    Aug 13, 2029 3 years left